Similarly, Hoda et al. [18] reported of a treatment response to atezolizumab and nab-paclitaxel of two patients with PD-L1 positive primary breast tumors but discordant PD-L1 negative metastatic lesions. Here, CD274 is linked to breast neoplasm.